[1]
|
F. D. Lowy, “Staphylococcus aureus Infections,” The New England Journal of Medicine, Vol. 339, 1998, pp. 520-532. doi:10.1056/NEJM199808203390806
|
[2]
|
M. P. Jevons, “‘Celbenin’-Resistant Staphylococci,” BMJ Journals, Vol. 124, No. 1961, pp. 124-125.
doi:10.1136/bmj.1.5219.124-a
|
[3]
|
A. Huletsky, R. Giroux, V. Rossbach, M. Gagnon, M. Vaillancourt, M. Bernier, F. Gagnon, K. Truchon, M. Bastien, F. J. Picard, A. Belkum, M. Ouellette, P. Roy, and M. Bergeron, “New Real Time PCR Assay for Rapid Identification of MRSA Directly from Specimens Containing a Mixture of Staphylococci,” Journal of Clinical Microbiology, Vol. 42, No. 5, 2004, pp. 1875-1884.
doi:10.1128/JCM.42.5.1875-1884.2004
|
[4]
|
J. Boyce and N. Havill, “Comparison of BD GeneOhm MRSA PCR versus the CHROMagar MRSA Assay for Screening Patients for the Presence of MRSA Strains,” Journal of Clinical Microbiology, Vol. 46, No. 1, 2008, pp. 350-351. doi:10.1128/JCM.02130-07
|
[5]
|
H. Chambers, “Methicillin Resistance in Staphylococci: Molecular and Biochemical Basis and Clinical Implication,” Journal of Clinical Microbiology Review, Vol. 10, No. 4, 1997, pp. 781-791.
|
[6]
|
D. Warren, R. Liao, L. Merz, M. Eveland and W. Dunne, “Detection of MRSA Directly from Nasal Swabs Specimens by a Real Time PCR Assay,” Journal of Clinical Microbiology, Vol. 42, No. 12, 2004, pp. 5578-5561.
doi:10.1128/JCM.42.12.5578-5581.2004
|
[7]
|
H. Fang and G. Hedin, “Rapid Screening and Identification of Methicillin-Resistant Staphylococcus aureus from Clinical Samples by Selective-Broth and Real-Time PCR Assay,” Journal of Clinical Microbiology, Vol. 41, No. 7, 2003, pp. 2894-2899.
doi:10.1128/JCM.41.7.2894-2899.2003
|
[8]
|
R. W. Smyth, G. Kahlmeter, L. B. Olsson and B. Hoffman, “Methods for Identifying Methicillin Resistance in Staphylococcus aureus,” Journal of Hospital Infection, Vol. 48, 2001, pp. 103-107. doi:10.1053/jhin.2001.0933
|
[9]
|
NCCLS: National Committee Clinical Standards. Performance standard for antimicrobial susceptibility test. Eight information supplement M100-S9. National committee Clinical standards, Villanova, 2003.
|
[10]
|
M. C. Enright, D. A. Robinson, G. Randle, E. J. Feil, H. Grundmann and B. G. Spratt, “The Evolutionary History of Methicillin-Resistant Staphylococcus aureus (MRSA),” Proceedings of the National Academy of Sciences of the USA, Vol. 99, No. 11, 2002, pp. 7687-7692.
|
[11]
|
J. M. Boyce, “Understanding and Controlling Methicillin Resistant Staphylococcus aureus Infections,” Infection Control and Hospital Epidemiology, Vol. 23, 2002, pp. 485-487. doi:10.1086/502092
|
[12]
|
S. Mulla, M. Patel, L. Shah, and G. Vaghela, “Study of Antibiotic Sensitivity Pattern of Methicillin Resistant Staphylococcus aureus,” Indian Journal of Critical Care Medicine, Vol. 11, No. 2, 2007, pp. 99-101.
doi:10.4103/0972-5229.33394
|
[13]
|
K. Rajaduraipandi, K. R. Mani, K. Panneerselvam, M. Mani, M. Bhaskar and P. Manikandan, “Prevalence and Antimicrobial Susceptibility Pattern of Methicillin Resistant Staphylococcus aureus: A Multicentre Study,” Indian Journal of Medical Microbiology, Vol. 24, No. 1, 2006, pp. 34-38. doi:10.4103/0255-0857.19892
|
[14]
|
I. M. Moussa and A. M. Hessan, “Rapid Detection of Community Acquired-Methicillin Resistance Staphylococcus aureus recovered from King Saudi Arabia,” African Journal of Microbiology Research, Vol. 4, No. 24, 2010, pp. 2804-2810.
|
[15]
|
S. Vidhani, P. L. Mehndiratta, and M. D. Mathur, “Study of Methicillin Resistant Staphyloccusaureus Isolates from High Risk Patients,” Indian Journal of Medical Microbiology, Vol. 19, No. 2, 2001, pp. 13-16.
|
[16]
|
T. B. Karchmer, L. J. Durbin, B. M. Simonton and B. M. Farr, “Cost-Effectiveness of Active Surveillance Cultures and Contact/Droplet Precautions for Control of Methicillin Resistant Staphylococcus aureus,” Journal of Hospital Infection, Vol. 51, No. 2, 2002, pp. 126-132.
doi:10.1053/jhin.2002.1200
|
[17]
|
G. Papia, M. Louie, A. Tralla, C. Johnson, V. Collins and A. E. Simor, “Screening High-Risk Patients for Methicillin-Resistant Staphylococcus aureus on Admission to the Hospital: Is It Cost Effective?” Infection Control and Hospital Epidemiology, Vol. 20, No. 47, 1999, pp. 473-477.
|
[18]
|
J. M. Fournier, A. Boutonnier and A. Bouvet, “Staphylococcus aureus Strains Which Are Not Identified by Rapid Agglutination Methods Are of Capsular Serotype 5,” Journal of Clinical Microbiology, Vol. 27, No. 6, 1989, pp. 1372-1374.
|
[19]
|
A. J. Grisold, E. Leitner, G. Muhlbauer, E. Marth and H. H. Kessler, “Detection of Methicillin-Resistant Staphylococcus aureus and Simultaneous Confirmation by Automated Nucleic Acid Extraction and Real-Time PCR,” Journal of Clinical Microbiology, Vol. 40, No. 7, 2002, pp. 2392-2397. doi:10.1128/JCM.40.7.2392-2397.2002
|
[20]
|
T. Y. Tan, S. Corden, R. Barnes and B. Cookson, “Rapid Identification of Methicillin-Resistant Staphylococcus aureus from Positive Blood Cultures by Real-Time Fluorescence PCR,” Journal of Clinical Microbiology, Vol. 39, No. 12, 2001, pp. 4529-4531.
doi:10.1128/JCM.39.12.4529-4531.2001
|